Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/1999
03/24/1999EP0902782A1 Urea derivatives as inhibitors of impdh enzyme
03/24/1999EP0902681A1 Inhibition of selectin binding
03/24/1999EP0716650B1 Indole and indoline derivatives as 5ht1d receptor antagonists
03/24/1999EP0667855B1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis
03/24/1999EP0598046B1 Cyclic ureas useful as antiarrhythmic and antifibrillatory agents
03/24/1999EP0563128B1 New 3,4-dihydroisoquinoline derivates and new pharmaceutical use of carbocyclically and heterocyclically annulated dihydropyridines
03/24/1999CN1211433A Capsule for removing blood stasis and activating blood flow
03/23/1999US5886020 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/23/1999US5886009 Quinuclidine derivative as a substance P antagonist
03/23/1999US5886008 5-arylindole derivatives
03/23/1999US5885800 DNA encoding tumor necrosis related receptor, TR4
03/23/1999US5885795 Methods of expressing angiostatic protein
03/23/1999US5885572 Administering polypeptide or active fragment to treat bacterial infections
03/23/1999CA2247735A1 Novel 5-membered ring heterocycles, their preparation, their use and pharmaceutical preparations comprising them
03/23/1999CA2181225C The use of sertraline to treat post myocardial infarction patients
03/23/1999CA2157393C Preparation for improving the blood supply containing hard magnetic particles
03/23/1999CA2130878C 4-aminopyrimidine derivatives
03/23/1999CA2096293C Alkene carboxylic acid derivatives, method of preparation thereof and pharmaceutical compositions containing them
03/23/1999CA2031505C Phospholipid derivative
03/23/1999CA2022611C Optical resolution method for 3s-(3-carboxybenzyl)-6-(5-fluoro-2-benzothiazolyl)methoxy-4s-chromanol
03/23/1999CA2008771C Pyridinium nitrate, its production and use
03/22/1999CA2244239A1 Novel era
03/22/1999CA2244237A1 A human lig-1 homolog (hlig-1)
03/18/1999WO1999013055A1 Human sigma receptor
03/18/1999WO1999013054A2 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
03/18/1999WO1999012968A2 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999WO1999012933A2 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999WO1999012931A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999WO1999012930A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their prepa ration and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999WO1999012926A1 Tetrahydro gamma-carbolines
03/18/1999WO1999012921A1 Thromboxane ligands
03/18/1999WO1999012916A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
03/18/1999WO1999012915A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999WO1999012640A1 Coated particles, methods of making and using
03/18/1999WO1999012559A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999WO1999012533A1 A method of modulating cellular activity
03/18/1999WO1999012523A1 Modulation of drug loading in multivesicular liposomes
03/18/1999WO1999012521A1 New foam-forming pharmaceutical composition
03/18/1999DE19740110A1 New hydroxy substituted benzomorphan derivatives
03/18/1999DE19737224A1 Pharmaceutical preparation for cardiovascular treatment
03/18/1999CA2304108A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999CA2303479A1 Human sigma receptor
03/18/1999CA2303440A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999CA2303422A1 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999CA2303249A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999CA2303176A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999CA2303152A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999CA2302710A1 New foam-forming pharmaceutical composition
03/18/1999CA2302555A1 Thromboxane ligands
03/18/1999CA2301807A1 Tetrahydro gamma-carbolines
03/18/1999CA2300387A1 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
03/18/1999CA2296358A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
03/18/1999CA2247551A1 Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
03/17/1999EP0902027A1 Indole and indazole derivatives, process for their preparation and the pharmaceutical compositions containing them
03/17/1999EP0901499A1 Adenosine derivatives
03/17/1999EP0901487A1 Novel 2,3 disubstituted-4(3h)-quinazolinones
03/17/1999EP0901482A1 Benzofuran carboxamides and their therapeutic use
03/17/1999EP0901474A1 Aryl pyrimidine derivatives
03/17/1999EP0901470A1 Indole derivatives useful as endothelin receptor antagonists
03/17/1999EP0901469A1 Arylalkylpiperazine compounds as antioxidants
03/17/1999EP0901466A1 Biphenylsulfonamide matrix metalloproteinase inhibitors
03/17/1999EP0901379A2 Type-2 chemokine binding proteins and methods of use therefor
03/17/1999EP0901373A1 Alpha v Beta 3 ANTAGONISTS
03/17/1999EP0789699B1 SPIRO[HETEROCYCLE-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE]-4'-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
03/17/1999EP0708774B1 IMIDAZO[1,2-a]PYRAZIN-4-ONE DERIVATIVES ANTAGONISTS OF AMPA AND NMDA RECEPTORS
03/17/1999EP0655058B1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
03/17/1999EP0626954B1 Benzocycloheptenes, benzoxepines and benzothiepines
03/17/1999EP0616536B1 Use of decorin or biglycan for the manufacture of a medicament in the treatment of diabetes-associated pathology
03/17/1999EP0565634B1 Angiotensin ii receptor blocking compositions
03/17/1999CN1211321A Methods for measurment and treatment predicated on presence of advanced glycosylation endproducts in tobacco and its combustion byproducts
03/17/1999CN1211251A 1,4-dihydropyridine compounds as bradykinin antagonists
03/17/1999CN1211238A Benzimidazole derivatives
03/17/1999CN1211183A Methods for preparation of biphenyl isoxazole sulfonamides
03/17/1999CN1211181A Use of pyruvate for retarding neutrophil infiltratration and morphologic loss in ischemic bowel
03/17/1999CN1211180A Method of treatment with compounds having RAG 'alpha' receptor specific or selective activity
03/17/1999CN1210719A Nutritive health products of wood frog oil
03/17/1999CN1042539C 11,21-bisphenyl-19-norpregnane derivatives
03/17/1999CN1042533C Substituted 1-(7-chloroquinolin-4-yl) pyrazole-3-carboxamide N-oxide derivatives, method of preparing them and the pharmaceutical compositions
03/17/1999CN1042532C Substituted phenyltrifluoethoxypropionic acid and its use
03/16/1999US5883294 Selective thyroid hormone analogs
03/16/1999US5883251 Enzyme inhibitors
03/16/1999US5883239 aroA
03/16/1999US5883133 Cardiovascular disorders
03/16/1999US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors
03/16/1999US5883116 3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/16/1999US5883114 Indolocarbazole imides and the use thereof
03/16/1999US5883113 Tyrosine kinase inhibitors; antiproliferative and anticarcinogenic agents; diabetes, arthritis, restenosis, atherosclerosis
03/16/1999US5883111 Heterocyclic compounds and their use as angiotensin antagonists
03/16/1999US5883099 Treatment of athersclerosis, pancreatitis obesity or hyperglycemia
03/16/1999US5883092 Pyrimidine derivatives as endothelin antagonists
03/16/1999US5883090 Endothelin receptor antagonists
03/16/1999US5883075 Hypotensive agent cyclic peptides
03/16/1999US5882925 Cdna contained in plasmids, amino acid sequences and cultures
03/16/1999US5882887 Proteins for genetic engineering
03/16/1999US5882885 Polypeptides and polynucleotides
03/16/1999US5882674 Transdermal therapeutic system comprising active substances representing carbon monoxide sources
03/16/1999US5882656 Useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, paget's disease, malignant hypercalcemia, and
03/16/1999US5882643 Identification and characterization of such factors which can play a role in preventing, ameliorating or correcting infections, dysfunctions or diseases. a novel lep gene of streptococcus pneumoniae.
03/16/1999CA2186513C Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
03/16/1999CA2158108C Compositions containing sertraline and a 5-ht1d receptor agonist or antagonist
1 ... 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 ... 1595